Aristo Bio-Tech and Lifescience IPO vs SVS Ventures IPO

Comparision between Aristo Bio-Tech and Lifescience IPO and SVS Ventures IPO.

IPO Details

Aristo Bio-Tech and Lifescience IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while SVS Ventures IPO is a SME Fixed Price Issue proposed to list at BSE SME.

	Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Fixed Price Issue
Listing At	NSE SME	BSE SME
Lead Managers	Beeline Capital Advisors Pvt Ltd	First Overseas Capital Limited
Registrar	Link Intime India Private Ltd	Bigshare Services Pvt Ltd
Market Maker	Sunflower Broking Private Limited	Svcm Securities Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Aristo Bio-Tech and Lifescience IPO is up to ₹13.05 Cr whereas the issue size of the SVS Ventures IPO is up to ₹11.24 Cr. The final issue price of Aristo Bio-Tech and Lifescience IPO is ₹72.00 per share and of SVS Ventures IPO is ₹20.00 per share.

	Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)	₹72.00 per share	₹20.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1600 shares	6000 shares
Fresh Issue Size	18,12,800 shares	56,22,000 shares
Fresh Issue Size (Amount)	up to ₹13.05 Cr	up to ₹11.24 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	18,12,800 shares	56,22,000 shares
Issue Size Total (Amount)	up to ₹13.05 Cr	up to ₹11.24 Cr

IPO Timetable

Aristo Bio-Tech and Lifescience IPO opens on Jan 16, 2023, while SVS Ventures IPO opens on Dec 30, 2022. The closing date of Aristo Bio-Tech and Lifescience IPO and SVS Ventures IPO is Jan 19, 2023, and Jan 04, 2023, respectively.

	Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
Anchor Bid Date
Issue Open	Jan 16, 2023	Dec 30, 2022
Issue Close	Jan 19, 2023	Jan 04, 2023
Basis Of Allotment (Tentative)	Jan 24, 2023	Jan 09, 2023
Initiation of Refunds (Tentative)	Jan 25, 2023	Jan 10, 2023
Credit of Share (Tentative)	Jan 27, 2023	Jan 11, 2023
Listing date (Tentative)	Jan 30, 2023	Jan 12, 2023
Anchor Lockin End date 1	Feb 23, 2023	Feb 08, 2023
Anchor Lockin End date 2	Apr 24, 2023	Apr 09, 2023

Financials

Aristo Bio-Tech and Lifescience IPO P/E ratio is 9.46, as compared to SVS Ventures IPO P/E ratio of 75.

Aristo Bio-Tech and Lifescience IPO

SVS Ventures IPO

Financial

Aristo Bio-Tech and Lifescience Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	8,785.12	20,123.94	100.74	1,230.51	731.01	1,970.97
31-Mar-21	8,141.73	16,722.96	107.57	1,338.08	838.58	2,224.77
31-Mar-22	7,700.16	16,603.29	146.17	1,484.25	984.75	2,548.43
30-Sep-22	10,869.14	12,907.49	258.90	1,743.15	1,243.65	2,935.53
Amount in ₹ Lakhs

SVS Ventures Limited Financial Information (Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	845.12	1348.6	25	54.53	641.79
31-Mar-21	1165.01	1355	26.61	81.14	646.36
31-Mar-22	1245.68	868.27	183.37	264.51	700.95
30-Jun-22	2501.07	129.99	14.34	2125.33	267.49
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100.00%

90.49%

Promoter Shareholding (Post-Issue)

73.37%

66.66%

P/E Ratio

9.46

Market Cap

₹49.02 Cr.

₹42.70 Cr.

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Aristo Bio-Tech and Lifescience IPO retail investors (RII) are offered 8,60,800 shares while in SVS Ventures IPO retail investors are offered 8,60,800 shares. Qualified institutional buyers (QIB) are offered in Aristo Bio-Tech and Lifescience IPO and in SVS Ventures IPO.

	Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
Anchor Investor Reserveration
Market Maker Reserveration	91,200 shares	2,82,000 shares
QIB
NII	8,60,800 shares	26,70,000 shares
RII	8,60,800 shares	26,70,000 shares
Employee
Others
Total	17,21,600 shares	53,40,000 shares

Bids Received (Subscription)

Aristo Bio-Tech and Lifescience IPO subscribed 217.72x in total, whereas SVS Ventures IPO subscribed 1.27x.

	Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
QIB (times)
NII (times)	285.84x	0.53x
Big NII (times)
Small NII (times)
RII (times)	149.59x	2.01x
Employee (times)
Other (times)
Total (times)	217.72x	1.27x

Compare with others

Aristo Bio-Tech and Lifescience IPO	SVS Ventures IPO
Shera Energy IPO	Aristo Bio-Tech and Lifescience IPO
Gayatri Rubbers and Chemicals IPO	Ducol Organics And Colours IPO
Earthstahl & Alloys IPO	Eastern Logica Infoway IPO
Transvoy Logistics India IPO	Chaman Metallics IPO
DHARNI Capital Services IPO	Rex Sealing and Packing Industries IPO
Ducol Organics And Colours IPO	Anlon Technology Solutions IPO
Eastern Logica Infoway IPO	Moxsh Overseas Educon IPO
Chaman Metallics IPO	RBM Infracon IPO
Rex Sealing and Packing Industries IPO	Homesfy Realty IPO
SVS Ventures IPO	Dollex Agrotech IPO

Comments

Add a public comment...